Jessica Chubak to Aged
This is a "connection" page, showing publications Jessica Chubak has written about Aged.
Connection Strength
1.894
-
Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
Score: 0.102
-
Factors associated with employment discontinuation among older and working age survivors of oropharyngeal cancer. Head Neck. 2019 11; 41(11):3948-3959.
Score: 0.081
-
Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Nov; 29(11):1093-1103.
Score: 0.076
-
An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events. Med Care. 2017 12; 55(12):e81-e87.
Score: 0.071
-
Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System. J Clin Gastroenterol. 2017 Aug; 51(7):650-655.
Score: 0.070
-
Association of worry about cancer to benefit finding and functioning in long-term cancer survivors. Support Care Cancer. 2017 05; 25(5):1417-1422.
Score: 0.067
-
Cancer survivors' experiences with insurance, finances, and employment: results from a multisite study. J Cancer Surviv. 2016 12; 10(6):1104-1111.
Score: 0.065
-
Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
Score: 0.063
-
Breast cancer recurrence in relation to antidepressant use. Cancer Causes Control. 2016 Jan; 27(1):125-36.
Score: 0.062
-
Psychometric investigation of benefit finding among long-term cancer survivors using the Medical Expenditure Panel Survey. Eur J Oncol Nurs. 2016 Feb; 20:31-5.
Score: 0.061
-
Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv. 2014 Jun; 8(2):229-38.
Score: 0.054
-
Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med. 2013 Nov; 57(5):671-8.
Score: 0.053
-
Predictors of 1-year change in patient activation in older adults with diabetes mellitus and heart disease. J Am Geriatr Soc. 2012 Jul; 60(7):1316-21.
Score: 0.049
-
Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst. 2012 Jun 20; 104(12):931-40.
Score: 0.049
-
Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol. 2012 Mar; 65(3):343-349.e2.
Score: 0.047
-
Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer. 2011 Jan 01; 128(1):227-32.
Score: 0.044
-
Cost of breast-related care in the year following false positive screening mammograms. Med Care. 2010 Sep; 48(9):815-20.
Score: 0.043
-
Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. 2009 Jul; 18(7):540-4.
Score: 0.040
-
Antidepressant medications and change in mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2009 Feb; 18(2):676-9.
Score: 0.039
-
Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat. 2008 Nov; 112(1):123-32.
Score: 0.036
-
Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy. Cancer Causes Control. 2007 Nov; 18(9):1001-7.
Score: 0.035
-
Effect of exercise on bone mineral density and lean mass in postmenopausal women. Med Sci Sports Exerc. 2006 Jul; 38(7):1236-44.
Score: 0.032
-
Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas. JAMA Netw Open. 2024 Apr 01; 7(4):e244611.
Score: 0.028
-
Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
Score: 0.025
-
Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43 302 primary care patients. J Cachexia Sarcopenia Muscle. 2022 Oct; 13(5):2492-2503.
Score: 0.025
-
Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer. JAMA. 2022 06 07; 327(21):2114-2122.
Score: 0.024
-
Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control. 2020 Jul; 31(7):631-640.
Score: 0.021
-
Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
Score: 0.021
-
Changes in use of opioid therapy after colon cancer diagnosis: a population-based study. Cancer Causes Control. 2019 Dec; 30(12):1341-1350.
Score: 0.020
-
Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
Score: 0.020
-
The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control. 2019 Sep; 30(9):979-987.
Score: 0.020
-
CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. Cancer Causes Control. 2019 Jan; 30(1):103-112.
Score: 0.019
-
Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis. Cancer Res. 2017 11 01; 77(21):6033-6041.
Score: 0.018
-
Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population. Cancer Epidemiol Biomarkers Prev. 2017 11; 26(11):1603-1610.
Score: 0.018
-
A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer. 2017 Nov 15; 123(22):4472-4480.
Score: 0.017
-
Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State. Cancer Causes Control. 2017 03; 28(3):241-246.
Score: 0.017
-
Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 09; 51(3):e67-75.
Score: 0.016
-
Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 10; 31(10):1190-7.
Score: 0.016
-
Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med. 2016 10; 51(4):e107-15.
Score: 0.016
-
Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med. 2016 Mar-Apr; 29(2):191-200.
Score: 0.016
-
Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):513-20.
Score: 0.016
-
Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data. J Natl Cancer Inst. 2016 Mar; 108(3).
Score: 0.016
-
Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016 Jan 15; 122(2):312-21.
Score: 0.015
-
An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21.
Score: 0.015
-
Do depressed newly diagnosed cancer patients differentially benefit from nurse navigation? Gen Hosp Psychiatry. 2015 May-Jun; 37(3):236-9.
Score: 0.015
-
Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014 Nov-Dec; 27(6):789-95.
Score: 0.014
-
Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014 Sep; 66:123-30.
Score: 0.014
-
Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1683-8.
Score: 0.014
-
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat. 2014 Apr; 144(2):405-16.
Score: 0.014
-
Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol. 2014 Jan 01; 32(1):12-8.
Score: 0.014
-
Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1588-99.
Score: 0.013
-
Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use. Ann Epidemiol. 2013 Jun; 23(6):349-54.
Score: 0.013
-
An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):301-11.
Score: 0.013
-
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
Score: 0.013
-
Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract. 2012 Nov; 8(6):e149-57.
Score: 0.012
-
Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling. Gynecol Oncol. 2012 Aug; 126(2):229-35.
Score: 0.012
-
Nonparticipation in a population-based trial to increase colorectal cancer screening. Am J Prev Med. 2012 Apr; 42(4):390-7.
Score: 0.012
-
Patient-reported care coordination: associations with primary care continuity and specialty care use. Ann Fam Med. 2011 Jul-Aug; 9(4):323-9.
Score: 0.011
-
Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010 Nov; 31(6):589-603.
Score: 0.011
-
Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol. 2009 Sep 20; 27(27):4508-14.
Score: 0.010
-
Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):895-9.
Score: 0.009
-
Effects of an exercise intervention on other health behaviors in overweight/obese post-menopausal women. Contemp Clin Trials. 2007 Jul; 28(4):472-81.
Score: 0.008
-
Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1099-105.
Score: 0.007
-
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004 Jan; 13(1):94-101.
Score: 0.007